Skip to main content

Table 2 Assessment of pulmonary function (spirometry and manovacuometry)

From: Pulmonary function and exercise tolerance are related to disease severity in pre-dialytic patients with chronic kidney disease: a cross-sectional study

Variables

Control

Stage 3

Stage 4

Stage 5

P

 

(CG = 9)

(G3 = 10)

(G4 = 10)

(G5 = 9)

 

Spirometry

     

FVC (%)

118.0 ± 136.7

101.7 ± 20.2

98.3 ± 15.1

97.3 ± 21.1

0.115

FEV, (%)

111.0 ± 10.4

100.4 ± 18.4

95.0 ± 13.1

92.1 ± 19.1

0.126

FEV,/FVC (%)

94.9 ± 4.5

99.3 ± 7.8

97.5 = 5.3

95.0 ± 4.0

0.333

Manovacuometry

     

PImax (%)

93.3 ± 14.3

63.2 ± 27.1

62.0 = 12.5

69.9 ± 29.0

0.061

PEmax (%)

108.4 ± 16.5

94.1 ± 21.9

84.4 = 16.4

89.6 ± 25.6

0.192

  1. FVC Forced Vital Capacity, FEV 1 Forced Expiratory Volume in the first second of forceful exhalation, PImax Maximum Inspiratory Pressure, PEmax Maximum Expiratory Pressure.